[Retracted] Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)

Table 1

Other possible drug combinations used to treat COPD and their pooled effect estimates (LABA on moderate-severe exacerbations) [6].

Combination.	Dosage, respectively	Hazard ratio at 95% credibility interval
Beclomethasone dipropionate/formoterol	200 µg/12 µg	0.96
Mometasone furoate/formoterol	200 µg/10 µg	0.68
Fluticasone propionate/salmeterol	500 µg/50 µg	0.81
Budesonide/formoterol	320 µg/9 µg	0.74
Fluticasone furoate/vilanterol	100 µg/25 µg	0.77